STAT3 and PD-L1 are negatively correlated with ATM and have impact on the prognosis of triple-negative breast cancer patients with low ATM expression-Reference-Cited by-同舟云学术

STAT3 and PD-L1 are negatively correlated with ATM and have impact on the prognosis of triple-negative breast cancer patients with low ATM expression

Published:2022-09-03 Issue:1 Volume:196 Page:45-56
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Song Yuan-Ming,Qian Xiao-Long,Xia Xiao-Qing,Li Ya-Qing,Sun Yuan-Yuan,Jia Yu-Mian,Wang Jin,Xue Hui-Qin,Gao Guang-Shen,Wang Xiao-Zi,Zhang Xin-Min,Guo Xiao-Jing^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-022-06679-0.pdf

Reference45 articles.

1. Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J, Cardoso F (2019) Breast cancer. Nat Rev Dis Primers 5(1):66. https://doi.org/10.1038/s41572-019-0111-2

2. Denkert C, von Minckwitz G, Darb-Esfahani S, Lederer B, Heppner BI, Weber KE, Budczies J, Huober J, Klauschen F, Furlanetto J, Schmitt WD, Blohmer J-U, Karn T, Pfitzner BM, Kümmel S, Engels K, Schneeweiss A, Hartmann A, Noske A, Fasching PA, Jackisch C, van Mackelenbergh M, Sinn P, Schem C, Hanusch C, Untch M, Loibl S (2018) Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol 19(1):40–50. https://doi.org/10.1016/s1470-2045(17)30904-x

3. Stanton SE, Adams S, Disis ML (2016) Variation in the incidence and magnitude of tumor-infiltrating lymphocytes in breast cancer subtypes: a systematic review. JAMA Oncol 2(10):1354–1360. https://doi.org/10.1001/jamaoncol.2016.1061

4. Stanton SE, Disis ML (2016) Clinical significance of tumor-infiltrating lymphocytes in breast cancer. J Immunother Cancer. https://doi.org/10.1186/s40425-016-0165-6

5. Tang H, Liang Y, Anders RA, Taube JM, Qiu X, Mulgaonkar A, Liu X, Harrington SM, Guo J, Xin Y, Xiong Y, Nham K, Silvers W, Hao G, Sun X, Chen M, Hannan R, Qiao J, Dong H, Peng H, Fu YX (2018) PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression. J Clin Investig 128(2):580–588. https://doi.org/10.1172/JCI96061

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The crosstalk between DNA-damage responses and innate immunity;International Immunopharmacology;2024-10

2. Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review;Animal Models and Experimental Medicine;2024-09-02

3. Inhibition of ATM promotes PD-L1 expression by activating JNK/c-Jun/TNF-α signaling axis in triple-negative breast cancer;Cancer Letters;2024-04

4. The predictive value of prognosis and therapeutic response for STAT family in pancreatic cancer;Heliyon;2023-05